NFATc1-IN-1是一种有效的 RANKL 诱导的破骨细胞形成抑制剂,IC50 为 1.57 μM。它通过减少 NFATc1 核转位,表现出抗破骨细胞作用,适用于破骨疾病研究。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | NFATc1-IN-1 is a potent inhibitor of RANKL-induced osteoclast formation, demonstrating an IC50 of 1.57 μM. It exhibits anti-osteoclastogenic effects by reducing RANKL-induced NFATc1 nuclear translocation and is suitable for research into osteoclastic diseases[1]. |
| 体外研究 | NFATc1-IN-1, at concentrations ranging from 0 to 2.5 μM over four days, displays strong inhibitory effects on osteoclast formation and function, ultimately leading to reduced bone resorption[1]. At concentrations between 1.5 and 2.5 μM over 24 hours, NFATc1-IN-1 prevents NFATc1 nuclear translocation and lowers NFATc1 levels[1]. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.67mL 0.53mL 0.27mL |
13.33mL 2.67mL 1.33mL |
26.66mL 5.33mL 2.67mL |
|
| CAS号 | 1912422-56-0 |
| 分子式 | C13H8F2INO2 |
| 分子量 | 375.1 |
| SMILES Code | O=C(NC1=CC=C(I)C=C1F)C2=CC(F)=CC=C2O |
| 别名 | |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 120 mg/mL(319.91 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
沪公网安备 31011702889066号
沪ICP备2024050318号-1